Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Thetrading999on May 07, 2018 8:16am
147 Views
Post# 27990250

News Lifestyle Delivery Systems Inc. announces CSPA Group,

News Lifestyle Delivery Systems Inc. announces CSPA Group,

ifestyle Delivery Systems Inc. announces CSPA Group, Inc. and LDS Agrotech Prepare for Natural Gas Power Generation at Cultivation and Nursery Facility

Lifestyle Delivery Systems Inc. announces CSPA Group, Inc. and LDS Agrotech Prepare for Natural Gas Power Generation at Cultivation and Nursery Facility

PR Newswire

VANCOUVER, British ColumbiaMay 7, 2018 /PRNewswire/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that CSPA Group, Inc. ("CSPA") together with LDS Agrotech Inc. ("LDS Agro") are preparing for commencement of natural gas power generation at the cultivation and nursery facility scheduled for the last week of May 2018.

CSPA and LDS Agro are finishing the installation of a 4-inch gas line to the natural gas generator and associated electrical connections to supply 480 3-phase power of over 4,200 amps to the cultivation and nursery facility in Adelanto. This is the final step in the completion of the cultivation and nursery projects. Upon completion, the Company will schedule its final inspection for the Certification of Occupancy of the cultivation division. Once the final Certificate of Occupancy is issued, CSPA will be able to apply for the State License to begin its cultivation of isogenic strains, specifically developed for the CannaStripsTM and Rveur product lines.

Brad Eckenweiler, CEO of LDS, stated, "This is an important step in controlling the ingredients that are used in our manufacturing process, which in turn allows for consistent quality and repeatable results in each of our products every time." CSPA intends to sell specific strains of seedlings to contract growers and repurchase the mature harvested plants for its manufacturing and production of CannaStripsTM and Rveur products.

CSPA has also taken delivery of 1,500 pounds of biomass for contract extraction with an anticipated yield of between 60 to 70 liters of high-grade extraction. CSPA continues to expand its extraction capabilities both in its quality and the daily quantity. The initial extraction results and the associated feedback from the biomass providers has caused CSPA to begin preparing the facility for possible long term contracts for producing white label extraction and distillation products. The Company will continue to keep the shareholders informed as information becomes available.

About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a licensed, state-compliant vertically integrated cannabis-related company. From our isogenic pollination nursery to our cutting edge, state-of-the-art production facility located in Southern California, LDS has become one of the most diverse, innovative and scientifically based cannabis companies throughout North America. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler
CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT: 
investor.relations@lifestyledeliverysystem.com  
1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.

 

This email was sent to you at edbeaudry@gmail.com by Stockwatch (www.stockwatch.com) as part of your package of Stockwatch services, and in accordance with your email preferences on file. You may unsubscribe at any time, or change your email preferences within Your Account settings at the Stockwatch website. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY. You may contact Stockwatch by email at webmaster@stockwatch.com, by phone at 1-800-268-6397 (1-604-687-1500), or by mail to Stockwatch, PO Box 10371, 700 West Georgia Street, Vancouver, BC, V7Y 1J6, Canada. "Stockwatch" is a registered trademark of Canjex Publishing Ltd. Copyright © 2018, Canjex Publishing Ltd. All rights reserved.

 
 
 
 
 
 
 
0.3 GB (2%) of 15 GB used
Last account activity: 19 minutes ago
Details
 
 
 
 
 

Bullboard Posts